---
document_datetime: 2025-10-24 13:57:02
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/rhokiinsa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: rhokiinsa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.1565982
conversion_datetime: 2025-12-30 10:19:45.009777
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Rhokiinsa

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                           |
|----------------------|----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|---------------------------------------------------|
| Variation type II /  | This was an application for a group of | 09/10/2025                          |                                             | SmPC                             | The SmPC section 6.5 has been updated as follows: |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000274637   | variations.   |
|---------------------|---------------|

<div style=\"page-break-after: always\"></div>

|                                       | the finished product - B.II.b.2.a Replacement or addition of a site where batch control/testing takes place - Accepted B.II.d.2 Change in test procedure for the finished product - B.II.d.2.a Minor changes to an approved test procedure - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.z Other changes - Accepted                                                                                                                                                                                                                                  |            |             |                                                                                                                                                                                                                                                                                                                                                                              |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IB / EMA/VR/0000278055 | C.I.3 Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet of human medicinal products intended to implement the outcome of a procedure concerning PSUR or PASS, or the outcome of the assessment done by the competent authority under Articles 45 or 46 of Regulation 1901/2006 - C.I.3.z Other variation - Accepted To update SmPC section 4.4 and 4.8 to include \"Reticular epithelial corneal oedema\" with the frequency not known as assessed as part of a PSUSA for products containing latanoprost / netarsudil. The package leaflet is updated accordingly. Furthermore, the MAH took this opportunity to remove the | 22/07/2025 | SmPC and PL | To update SmPC section 4.4 and 4.8 to include \"Reticular epithelial corneal oedema\" with the frequency not known as assessed as part of a PSUSA for products containing latanoprost / netarsudil. The package leaflet is updated accordingly. Furthermore, the MAH took this opportunity to remove the local representative for UK/NI in line with the current QRD template. |

<div style=\"page-break-after: always\"></div>

|                                       | local representative for UK/NI in line with the current QRD template.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |     |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000246584 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in the manufacturing process of the active substance or change in the manufacturer (including where relevant quality control testing sites) of the active substance, where no Ph. Eur. Certificate of Suitability is part of the approved dossier - B.I.a.1.f Changes to quality control testing arrangements for the active substance-replacement or addition of a site where batch control/testing takes place - Accepted | 13/03/2025 | N/A |